Glucocorticoid signaling in the heart: A cardiomyocyte perspective

Robert H Oakley1, John A Cidlowski1

  • 1Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, 111 TW Alexander Drive, P.O. Box 12233, MD F3-07, Research Triangle Park, North Carolina 27709, USA.

Insights

Glucocorticoid receptor (GR) signaling in heart cells is vital for normal heart development and function. Mineralocorticoid receptor (MR) signaling in these cells contributes to cardiac disease progression.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Heart failure is a major cause of death globally.
  • Glucocorticoids are critical stress hormones with known cardiovascular effects.
  • The direct role of glucocorticoid signaling in the heart remains incompletely understood.

Purpose of the Study:

  • To review the role of glucocorticoid signaling in cardiomyocytes.
  • To discuss insights from genetic mouse models targeting GR and MR in the heart.
  • To elucidate the impact of cardiomyocyte glucocorticoid signaling on heart physiology and pathophysiology.

Main Methods:

  • Utilizing transgenic mouse models to specifically target glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) in cardiomyocytes.
  • Investigating the in vivo function of GR and MR signaling pathways within the heart.
  • Analyzing the physiological and pathophysiological consequences of altered glucocorticoid signaling in the heart.

Main Results:

  • GR signaling in cardiomyocytes is essential for normal cardiac development and function.
  • MR signaling in cardiomyocytes plays a role in the development and progression of cardiac disease.
  • Genetic models provide new understanding of direct cardiomyocyte glucocorticoid signaling.

Conclusions:

  • Cardiomyocyte glucocorticoid signaling, mediated by GR and MR, significantly influences heart health.
  • GR signaling is protective, while MR signaling is detrimental in the context of cardiac disease.
  • Further research into these pathways can inform therapeutic strategies for heart failure.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.8K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.4K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
909
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
13.0K